Compare LEXX & JCSE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | LEXX | JCSE |
|---|---|---|
| Founded | 2004 | 1999 |
| Country | Canada | Singapore |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Miscellaneous manufacturing industries |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 8.7M | 7.8M |
| IPO Year | 2011 | 2022 |
| Metric | LEXX | JCSE |
|---|---|---|
| Price | $12.93 | $1.47 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $1.50 | N/A |
| AVG Volume (30 Days) | ★ 70.1K | 29.5K |
| Earning Date | 04-13-2026 | 05-14-2026 |
| Dividend Yield | N/A | ★ 8.18% |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $705,923.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $601.47 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 52.05 | N/A |
| 52 Week Low | $0.35 | $0.77 |
| 52 Week High | $13.61 | $2.50 |
| Indicator | LEXX | JCSE |
|---|---|---|
| Relative Strength Index (RSI) | 72.81 | 44.32 |
| Support Level | $0.62 | $1.27 |
| Resistance Level | $12.89 | $1.45 |
| Average True Range (ATR) | 1.39 | 0.15 |
| MACD | -0.03 | -0.03 |
| Stochastic Oscillator | 76.11 | 16.22 |
Lexaria Bioscience Corp is a biotechnology company focused on enhancing the bioavailability of active pharmaceutical ingredients using its patented DehydraTECH drug delivery technology. DehydraTECH improves absorption, effectiveness, and tolerability and can be applied to APIs such as GLP-1 and GIP drugs, vitamins, pain medications, hormones, antivirals, nicotine and cannabinoids across therapeutic areas including diabetes, weight loss, epilepsy, hypertension, and heart disease. It can be used in formats such as tablets, capsules, oral suspensions, foods, beverages, and pouches, and supports pharmaceuticals, nutraceuticals, over-the-counter products, and consumer packaged goods. The Company operates one segment: IP licensing, generating revenue from licensing its DehydraTECH technology.
JE Cleantech Holdings Ltd is engaged in the manufacturing and selling of cleaning systems and other equipment that can be categorized into four different categories, namely aqueous washing systems, plating and cleaning systems, train cleaning systems, and other equipment, such as filtration units. The company is also into designing, developing, and manufacturing other cleaning systems for various industrial end-use applications using its R&D and engineering capabilities. The company has two operating segments namely sale of cleaning systems and other equipment and provision of centralized dishware washing and general cleaning services. Geographically, the company derives a majority of its revenue from Singapore.